~~<i id='61BCB113A0'><strike id='61BCB113A0'><tt id='61BCB113A0'><pre id='61BCB113A0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

hotspot

author：hotspot 2025-08-24 04:07:03 - browse：87396

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： President Biden's budget: Here's what you might have missed

entertainment

explore

leisure time

entertainment

Wikipedia

entertainment

TheFDAisrampingupitseffortstoforcevapeshopsandotherretailerstostopsellingElfBarandEscoBarproducts.PA

WSS

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

In early work, researchers turn to CRISPR to treat Alzheimer's

HHS secretary Becerra pressed on Change HealthCare cyberattack

Listen: Wegovy in the brain & pivotal Alzheimer's data

Cosmetics set for new safety regulation. Why the industry is on board

STAT Virtual Event: The State of Biosimilars: What to Watch

Wikipedia

hotspot

entertainment

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AI can’t replace a physician’s gut feeling

Supreme Court strikes down use of affirmative action

Amid AI frenzy, a top HHS official's quest to create safeguards

State Dept. review finds Biden bears some blame for Afghanistan failures

Medicare has a new plan to address drug shortages

Hollywood unions extend contract negotiations for actors

How many hemophilia patients actually want gene therapy?

Trump demands the U.S. pay no more for drugs than other countries … again

How dance can help nurses traumatized by Covid

explore

Key House panel plots a new health care package

UCLA team creates talking throat patch for voice disorders

Medicare coverage of Wegovy, once blocked, now looks possible

AI can’t replace a physician’s gut feeling

Doctors find melanoma drugs effective against rare brain cancer

First U.S. drug developed to treat liver disease MASH is approved

leisure time

entertainment

Wikipedia

entertainment